A combination of two targeted therapies already shown to be effective in breast cancer packs an effective one-two punch against a subset of gastric cancers that have a specific genetic mutation, a new study has found.
Herceptin and Tykerb effective against a subset of gastric cancers, study suggests
March 14th, 2010 by Newspublichealth.com
Leave a Reply
Sorry, no posts matched your criteria.